The cancer radiation therapy market continues to grow as healthcare systems invest in targeted cancer treatment technologies. Radiation therapy, used in over half of all cancer cases, is shifting toward precision and personalization.
Major Developments:
- Expansion of intensity-modulated (IMRT) and stereotactic radiotherapy (SBRT)
- Rise of AI-assisted planning systems for dose targeting
- Growth of proton therapy centers in developed markets
Treatment Types:
- External Beam Radiation
- Brachytherapy (internal)
- Radiopharmaceuticals (systemic)
End Users:
- Oncology Hospitals
- Radiotherapy Clinics
- Academic Research Institutes
Global Focus:
- North America leads in innovation and early adoption.
- Asia-Pacific offers scale through increasing cancer prevalence and access.
Outlook to 2031: Radiation oncology is entering a new era of personalized therapy, driven by tech innovations and demand for non-invasive treatments.
